Actinomycin D versus methotrexate-folinic acid as

International Journal of Gynecological Cancer

Volumn 19, Issue 5, 2009, Pages 985-988

  Lertkhachonsuk, Arb Aroon ^a   Israngura, Nathpong ^a   Wilailak, Sarikapan ^a   Tangtrakul, Somsak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Actinomycin; Gestational trophoblastic neoplasia; Methotrexate

Indexed keywords

CHORIONIC GONADOTROPIN; DACTINOMYCIN; FOLINIC ACID; METHOTREXATE; ANTINEOPLASTIC AGENT; VITAMIN B COMPLEX;

ADULT; ALOPECIA; ARTICLE; BLOOD LEVEL; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LIVER TOXICITY; METHODOLOGY; MUCOSA INFLAMMATION; NEUTROPENIA; ORGANIZATION; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; THROMBOCYTOPENIA; TROPHOBLASTIC TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; LUNG TUMOR; MAXIMUM TOLERATED DOSE; METASTASIS; PATHOLOGY; PREGNANCY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DACTINOMYCIN; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; LEUCOVORIN; LUNG NEOPLASMS; MAXIMUM TOLERATED DOSE; METHOTREXATE; NEOPLASM STAGING; PREGNANCY; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 69449107358     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a8333d     Document Type: Article

References (21)

1. Osborne R, Gerulath A. What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. J Reprod Med. 2004;49:602-616.
2. Ngan S, Seckl MJ. Gestational trophoblastic neoplasia management: an update. Curr Opin Oncol. 2007;19:486-491.
3. Burger RA, Creasman WT. Gestational trophoblastic neoplasia. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 6th ed. St Louis, MO: Mosby; 2002:185-210.
4. Kohorn EI. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use. J Reprod Med. 1991;36:49-55.
5. Berkowitz RS, Goldstein DP, Bernstein MR. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol. 1986;23:111-118.
6. Foulmann K, Guastalla JP, Caminet N, et al. What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence. Gynecol Oncol. 2006;102:103-110.
7. Bagshawe KD, Dent J, Newlands ES, et al. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol. 1989;96:795-802.
8. McNeish IA, Strickland S, Holden L, et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol. 2002;20:1838-1844.
9. Khan F, Everard J, Ahmed S, et al. Br J Cancer. 2003;89:2197-2201.
10. Goldstein DP, Winig P, Shirley RL. Actinomycin D as initial therapy of gestational trophoblastic disease. A reevaluation. Obstet Gynecol. 1972;39:341-345.
11. Kohorn EI. Decision making for chemotherapy administration in patients with low risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 1996;6:279-285.
12. Lurain JR, Brewer JI, Torok EE, et al. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol. 1982;60:354-360.
13. Osathanondh R, Goldstein DP, Pastorfide GB. Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer. 1975; 36:863-866.
14. Petrilli ES, Morrow CP. Actinomycin D toxicity in the treatment of trophoblastic disease: a comparison of the five-day course to single-dose administration. Gynecol Oncol. 1980;9:18-22.
15. Gilani MM, Yarandi F, Eftekhar Z, et al. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia. Aust N Z J Obstet Gynaecol. 2005;45:161-164.
16. FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet. 2002;77:285-287.
17. World Health Organization. Handbook for Reporting Results of Cancer Treatment. WHO offset publication No. 48. Geneva, Switzerland: WHO; 1979:16-21.
18. Srisomboon J, Suprasert P, Phongnarisorn C, et al. Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia. J Med Assoc Thai. 2005;88:886-890.
19. Tonanont M, Inthasorn P, Boriboonhirunsarn D, et al. Response to initial treatment of low and intermediate risk gestational trophoblastic disease with methotrexate and folinic acid. J Med Assoc Thai. 2005;88: 1349-1354.
20. Petrilli ES, Twiggs LB, Blessing JA, et al. Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group. Cancer. 1987;60:2173-2176.
21. Kohorn EI. Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance? Gynecol Oncol. 2002;85:36-39.